REPL

NASDAQStock$8.91+0.44 (+5.19%)
Mkt Cap 736.1MP/E Div Yield Beta 0.91Vol 1.6M
52W$1.70
$12.63

ETFs That Hold REPL (Replimune Group, Inc.)

1M

+62.64%

3M

+17.12%

6M

-13.37%

YTD

-3.15%

1Y

-12.84%

3Y

-64.23%

5Y

-75.14%

ETFs That Hold REPL

Replimune Group, Inc. is held by 54 ETFs. The largest position by market value is in XBI (State Street SPDR S&P Biotech ETF).

ETFFund NameWeight
XBIState Street SPDR S&P Biotech ETF0.30%
IWMiShares Russell 2000 ETF0.01%
VTIVanguard Total Stock Market ETF0.00%
IWNiShares Russell 2000 Value ETF0.02%
IBBiShares Biotechnology ETF0.07%
VXFVanguard Extended Market ETF0.01%
SCHASchwab U.S. Small-Cap ETF0.02%
VTWOVanguard Russell 2000 ETF0.02%
DFASDimensional - US Small Cap ETF0.01%
IWCiShares Micro-Cap ETF0.11%
PRFZInvesco RAFI US 1500 Small-Mid ETF0.05%
ITOTiShares Core S&P Total U.S. Stock Market ETF0.00%
CNCRLoncar Cancer Immunotherapy ETF3.54%
DFACDimensional - US Core Equity 2 ETF0.00%
CANCTema Oncology ETF0.29%
SCHBSchwab U.S. Broad Market ETF0.00%
VHTVanguard Health Care ETF0.00%
BBCVirtus Biotech Clinical Trials ETF0.74%
RSSLGlobal X - Russell 2000 ETF0.02%
SMMDiShares Russell 2500 ETF0.01%

Excludes leveraged and inverse ETFs.

Page 1 of 3Next

Frequently Asked Questions

How many ETFs hold REPL?
Replimune Group, Inc. (REPL) is held by 54 ETFs (excluding leveraged and inverse funds). The largest position by market value is in XBI (State Street SPDR S&P Biotech ETF).
What is the largest ETF that holds REPL?
By fund size, XBI (State Street SPDR S&P Biotech ETF) with $8.07B in AUM holds 0.30% of its portfolio in REPL, representing $23.8M in market value.
What percentage of CNCR is REPL?
REPL makes up 3.54% of CNCR (Loncar Cancer Immunotherapy ETF), making it one of the largest positions in that fund.
Is REPL in the S&P 500?
REPL is not currently a component of the S&P 500 index based on available ETF holdings data.
FREE DOWNLOAD

The Beginner's Guide to ETFs

20 pages. Zero fluff. Everything you need to start investing in ETFs.

No spam. Unsubscribe anytime.